Mena FN

T-Knife Therapeutics Announces Authorization Of Clinical Trial Application For TK-6302, A Multi-Armored, CRISPR Based T Cell Therapy For Solid Tumors

(MENAFN- GlobeNewsWire - Nasdaq) - Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation SAN FRANCISCO and BERLIN, March 03, 2026 ...
Yahoo Finance

T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors

SAN FRANCISCO and BERLIN, March 03, 2026 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing next-generation T cell therapies to fight cancer, today announced the ...
IEEE

Land Remote Sensing Applications Using Spaceborne GNSS Reflectometry: A Comprehensive Overview

Abstract: The refracted, reflected, and scattered signals from global navigation satellite systems (GNSSs) have been successfully used for remote sensing (RS) of the Earth's surface and atmosphere, ...
IEEE

FSO System Optimization for 6G Applications: Using Metaheuristic Algorithms

This paper investigates the potential improvements in Free Space Optics (FSO) communication systems using Particle Swarm Optimization (PSO) and the Pachycondyla Apicalis Algorithm (API). FSO ...
The Conversation

Using AI responsibly means knowing when not to use it

Sam Illingworth does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...